Effect of Exercise Mode in Breast Cancer-Related Lymphedema (Lymphedema)
8 septembre 2021 mis à jour par: Maged Basha, Qassim University
Effect of Exercise Mode on Physical Function and Quality of Life in Breast Cancer-Related Lymphedema: A Randomized Controlled Trial
Gaining a greater understanding of how each exercise mode affects lymphedema, as well as other health-related outcomes will improve exercise prescription guidelines relevant to this specific lymphedema.
Therefore, the purpose of this work was to compare the effects of Xbox kinect rehabilitation and resistance exercises on limb volume, symptoms severity, physical function, and quality of life in women with Breast cancer-related lymphedema.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Breast cancer-related lymphedema is a common and debilitating side effect of cancer treatment.
This study compared the effect of Xbox kinect rehabilitation and resistance exercises on breast cancer-related lymphedema volume and severity, as well as participant's physical function and quality of life.
Women diagnosed with unilateral breast cancer related lymphedema were randomly divided into two groups: the kinect based rehabilitation group KBRG and resistance exercise group REG.
woman in The KBRG received virtual reality therapy using Xbox Kinect-based games, the REG received resistance training in addition both groups received complex decongestive physiotherapy.
The intervention was five sessions per week for 8 weeks.
The outcome measures included limb volume, symptoms severity, physical function (muscle strength and range of motion) and quality of life.
All these outcomes were assessed at pretreatment (baseline) and after the end of treatment at week eight (W8).
Type d'étude
Interventionnel
Inscription (Réel)
52
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Cairo, Egypte, 11241
- Shorook Physical Therapy Centers
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
30 ans à 65 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Femelle
La description
Inclusion Criteria:
- Age more than 30.
- Histological diagnosis of breast cancer at least 1 year prior to the study.
- Clinical diagnosis of unilateral Breast cancer-related lymphedema and obtained medical clearance from their medical oncologists or surgeons.
- Clinical diagnosis of lymphedema was defined as having at least a 5 % inter-limb discrepancy in volume or circumference.
Exclusion Criteria:
- Unstable lymphedema, receiving intensive therapy within the previous 3 months.
- A musculoskeletal, cardiovascular and/or neurological disorder that could inhibit them from exercising.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Virtual Reality Group
The Kinect based rehabilitation group received virtual reality therapy using Xbox Kinect-based games, in addition to complex decongestive physiotherapy.
The intervention was led once per day, five days a week, over 8 weeks.
All participants wearing multilayer bandage or compression stocking during training to avoid exacerbation of the lymphedema in the affected limb.
|
Intervention was led once per day, five days a week, over 8 weeks.
Autres noms:
|
|
Expérimental: Resistance exercise Group
The resistance exercise group received resistance training, in addition to complex decongestive physiotherapy.
The intervention was led once per day, five days a week, over 8 weeks.
All participants wearing multilayer bandage or compression stocking during training to avoid exacerbation of the lymphedema in the affected limb.
|
Intervention was led once per day, five days a week, over 8 weeks.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Limb volume measurement
Délai: at baseline
|
assessed by circumference measurements using a non-elastic tape.
Measures started just distal to the metacarpal-phalangeal joints and were taken at 4-cm intervals up the arm until the base of the axilla.
|
at baseline
|
|
Limb volume measurement
Délai: after 8 weeks
|
assessed by circumference measurements using a non-elastic tape.
Measures started just distal to the metacarpal-phalangeal joints and were taken at 4-cm intervals up the arm until the base of the axilla.
|
after 8 weeks
|
|
Limb volume measurement
Délai: after 12 weeks
|
assessed by circumference measurements using a non-elastic tape.
Measures started just distal to the metacarpal-phalangeal joints and were taken at 4-cm intervals up the arm until the base of the axilla.
|
after 12 weeks
|
|
Health-related quality of life, Medical Outcomes Study short-form (SF-36)
Délai: at baseline
|
assessed using the Medical Outcomes Study short-form (SF-36).
Outcomes of physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role emotional and mental health domains were reported as norm-based scores.
|
at baseline
|
|
Health-related quality of life, Medical Outcomes Study short-form (SF-36)
Délai: after 8 weeks
|
assessed using the Medical Outcomes Study short-form (SF-36).
Outcomes of physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role emotional and mental health domains were reported as norm-based scores.
|
after 8 weeks
|
|
Health-related quality of life, Medical Outcomes Study short-form (SF-36)
Délai: after 12 weeks
|
assessed using the Medical Outcomes Study short-form (SF-36).
Outcomes of physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role emotional and mental health domains were reported as norm-based scores.
|
after 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Shoulder range of motion
Délai: at baseline
|
Active flexion and abduction of the shoulder were assessed with the elbow extended in the supine position.
External rotation was measured while the shoulder was adducted and in neutral position with the forearm in neutral supination and pronation while sitting on a chair.
|
at baseline
|
|
Shoulder range of motion
Délai: after 8 weeks
|
Active flexion and abduction of the shoulder were assessed with the elbow extended in the supine position.
External rotation was measured while the shoulder was adducted and in neutral position with the forearm in neutral supination and pronation while sitting on a chair.
|
after 8 weeks
|
|
Shoulder range of motion
Délai: after 12 weeks
|
Active flexion and abduction of the shoulder were assessed with the elbow extended in the supine position.
External rotation was measured while the shoulder was adducted and in neutral position with the forearm in neutral supination and pronation while sitting on a chair.
|
after 12 weeks
|
|
Visual analogue scale
Délai: at baseline
|
used to quantify the severity of perceived pain, heaviness, and tightness.
Participants rated their symptom severity from no pain/no discomfort (score = 0) to very severe pain/worst imaginable discomfort (score = 10)
|
at baseline
|
|
Visual analogue scale
Délai: after 8 weeks
|
used to quantify the severity of perceived pain, heaviness, and tightness.
Participants rated their symptom severity from no pain/no discomfort (score = 0) to very severe pain/worst imaginable discomfort (score = 10)
|
after 8 weeks
|
|
Visual analogue scale
Délai: after 12 weeks
|
used to quantify the severity of perceived pain, heaviness, and tightness.
Participants rated their symptom severity from no pain/no discomfort (score = 0) to very severe pain/worst imaginable discomfort (score = 10)
|
after 12 weeks
|
|
Muscle strength
Délai: at baseline
|
The affected upper extremity flexion, abduction, and external rotation muscle strength were measured during maximal voluntary isometric muscle contraction with the J Tech Commender Muscle Tester (Salt Lake City, Utah, USA) handheld dynamometer according to reported positions.
|
at baseline
|
|
Muscle strength
Délai: after 8 weeks
|
The affected upper extremity flexion, abduction, and external rotation muscle strength were measured during maximal voluntary isometric muscle contraction with the J Tech Commender Muscle Tester (Salt Lake City, Utah, USA) handheld dynamometer according to reported positions.
|
after 8 weeks
|
|
Muscle strength
Délai: after 12 weeks
|
The affected upper extremity flexion, abduction, and external rotation muscle strength were measured during maximal voluntary isometric muscle contraction with the J Tech Commender Muscle Tester (Salt Lake City, Utah, USA) handheld dynamometer according to reported positions.
|
after 12 weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Maged Basha, PhD, College of medical rehabilitation, Qassim University
- Directeur d'études: Fatma Alzahraa Kamel, PhD, Cairo University
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Vicini F, Shah C, Arthur D. The Increasing Role of Lymphedema Screening, Diagnosis and Management as Part of Evidence-Based Guidelines for Breast Cancer Care. Breast J. 2016 May;22(3):358-9. doi: 10.1111/tbj.12586. Epub 2016 Feb 29. No abstract available.
- Morgan PA, Franks PJ, Moffatt CJ. Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2005 Mar;2(1):47-62. doi: 10.1111/j.1742-4801.2005.00066.x.
- Aguilar-Lazcano CA, Rechy-Ramirez EJ, Hu H, Rios-Figueroa HV, Marin-Hernandez A. Interaction Modalities Used on Serious Games for Upper Limb Rehabilitation: A Systematic Review. Games Health J. 2019 Oct;8(5):313-325. doi: 10.1089/g4h.2018.0129. Epub 2019 Jul 9.
- Basha MA, Aboelnour NH, Alsharidah AS, Kamel FH. Effect of exercise mode on physical function and quality of life in breast cancer-related lymphedema: a randomized trial. Support Care Cancer. 2022 Mar;30(3):2101-2110. doi: 10.1007/s00520-021-06559-1. Epub 2021 Oct 20.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
15 janvier 2019
Achèvement primaire (Réel)
20 avril 2020
Achèvement de l'étude (Réel)
5 mai 2020
Dates d'inscription aux études
Première soumission
21 janvier 2021
Première soumission répondant aux critères de contrôle qualité
21 janvier 2021
Première publication (Réel)
26 janvier 2021
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
16 septembre 2021
Dernière mise à jour soumise répondant aux critères de contrôle qualité
8 septembre 2021
Dernière vérification
1 septembre 2021
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2449PT
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
OUI
Description du régime IPD
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Délai de partage IPD
6 months after publication
Critères d'accès au partage IPD
relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .